Titre:
  • Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: results of a feasibility study.
Auteur:Cardoso, Fatima; Ferreira Filho, Antonio Fabiano; Crown, John; Dolci, Stella; Paesmans, Marianne; Riva, Angelo; Di Leo, Angelo; Piccart-Gebhart, Martine
Informations sur la publication:Anticancer research, 21, 1B, page (789-795)
Statut de publication:Publié, 2001
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Alopecia -- chemically induced
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Arrhythmias, Cardiac -- chemically induced
Bone Marrow Diseases -- chemically induced
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Breast Neoplasms -- surgery
Chemotherapy, Adjuvant -- adverse effects
Combined Modality Therapy
Digestive System Diseases -- chemically induced
Doxorubicin -- administration & dosage
Doxorubicin -- adverse effects
Drug Administration Schedule
Drug Eruptions -- etiology
Fatigue -- chemically induced
Feasibility Studies
Female
Humans
Lymphatic Metastasis
Mastectomy
Middle Aged
Nervous System Diseases -- chemically induced
Paclitaxel -- administration & dosage
Paclitaxel -- adverse effects
Paclitaxel -- analogs & derivatives
Pain -- chemically induced
Pilot Projects
Prospective Studies
Radiotherapy, Adjuvant
Taxoids
Note générale:Clinical Trial
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0250-7005
info:pmid/11299845